IMA
Price
$13.71
Change
+$0.36 (+2.69%)
Updated
Sep 3 closing price
Capitalization
153.36M
63 days until earnings call
MNOV
Price
$1.32
Change
+$0.01 (+0.76%)
Updated
Sep 3 closing price
Capitalization
64.74M
70 days until earnings call
Interact to see
Advertisement

IMA vs MNOV

Header iconIMA vs MNOV Comparison
Open Charts IMA vs MNOVBanner chart's image
ImageneBio
Price$13.71
Change+$0.36 (+2.69%)
Volume$11.15K
Capitalization153.36M
Medicinova
Price$1.32
Change+$0.01 (+0.76%)
Volume$43.14K
Capitalization64.74M
IMA vs MNOV Comparison Chart in %
Loading...
IMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMA vs. MNOV commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMA is a Buy and MNOV is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (IMA: $13.36 vs. MNOV: $1.31)
Brand notoriety: IMA and MNOV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMA: 6% vs. MNOV: 39%
Market capitalization -- IMA: $153.36M vs. MNOV: $64.74M
IMA [@Biotechnology] is valued at $153.36M. MNOV’s [@Biotechnology] market capitalization is $64.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMA’s FA Score shows that 1 FA rating(s) are green whileMNOV’s FA Score has 0 green FA rating(s).

  • IMA’s FA Score: 1 green, 4 red.
  • MNOV’s FA Score: 0 green, 5 red.
According to our system of comparison, IMA is a better buy in the long-term than MNOV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMA’s TA Score shows that 3 TA indicator(s) are bullish while MNOV’s TA Score has 6 bullish TA indicator(s).

  • IMA’s TA Score: 3 bullish, 4 bearish.
  • MNOV’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, MNOV is a better buy in the short-term than IMA.

Price Growth

IMA (@Biotechnology) experienced а -1.98% price change this week, while MNOV (@Biotechnology) price change was -3.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +16.10%, and the average quarterly price growth was +32.67%.

Reported Earning Dates

IMA is expected to report earnings on Nov 06, 2025.

MNOV is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMA($153M) has a higher market cap than MNOV($64.7M). IMA YTD gains are higher at: 714.634 vs. MNOV (-37.619).
IMAMNOVIMA / MNOV
Capitalization153M64.7M236%
EBITDAN/A-13.28M-
Gain YTD714.634-37.619-1,900%
P/E RatioN/AN/A-
RevenueN/A135K-
Total CashN/A34.3M-
Total DebtN/A302K-
FUNDAMENTALS RATINGS
MNOV: Fundamental Ratings
MNOV
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
77
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
17

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMAMNOV
RSI
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 7 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 13 days ago
83%
Bullish Trend 9 days ago
70%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 22 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
IMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GTMEF41.95N/A
N/A
Globe Telecom, Inc.
HLFN33.44N/A
N/A
Home Loan Financial Corp.
SNMRF6.00N/A
N/A
Snam S.p.A.
EWPMF0.02N/A
N/A
East West Petroleum Corp.
GAMI24.40-0.04
-0.16%
GAMCO Investors, Inc.

IMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMA has been closely correlated with CELC. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if IMA jumps, then CELC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMA
1D Price
Change %
IMA100%
-0.30%
CELC - IMA
86%
Closely correlated
+4.59%
INCY - IMA
28%
Poorly correlated
+1.62%
TRML - IMA
24%
Poorly correlated
+0.73%
MNOV - IMA
23%
Poorly correlated
N/A
ALXO - IMA
20%
Poorly correlated
-11.97%
More

MNOV and

Correlation & Price change

A.I.dvisor tells us that MNOV and TIL have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MNOV and TIL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNOV
1D Price
Change %
MNOV100%
N/A
TIL - MNOV
28%
Poorly correlated
+8.22%
NEVPF - MNOV
24%
Poorly correlated
N/A
IMA - MNOV
23%
Poorly correlated
-0.30%
ALT - MNOV
23%
Poorly correlated
-2.09%
XBIO - MNOV
22%
Poorly correlated
+6.61%
More